These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

751 related articles for article (PubMed ID: 29596039)

  • 21. Significance of Subcategory Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Showing Both Cytologic and Architectural Atypia in Thyroid Aspiration Cytology.
    Jung YY; Jung S; Lee HW; Oh YL
    Acta Cytol; 2015; 59(5):370-6. PubMed ID: 26529329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RISK OF MALIGNANCY IN THYROID CYTOLOGY: THE IMPACT OF THE RECLASSIFICATION OF NONINVASIVE FOLLICULAR THYROID NEOPLASM WITH PAPILLARY-LIKE NUCLEAR FEATURES (NIFTP).
    Ventura M; Melo M; Fernandes G; Carrilho F
    Endocr Pract; 2019 Jul; 25(7):642-647. PubMed ID: 30865528
    [No Abstract]   [Full Text] [Related]  

  • 23. Thyroid nodules with atypia or follicular lesions of undetermined significance (Bethesda Category III): importance of ultrasonography and cytological subcategory.
    Rosario PW
    Thyroid; 2014 Jul; 24(7):1115-20. PubMed ID: 24684285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High risk of malignancy in cases with atypia of undetermined significance on fine needle aspiration of thyroid nodules even after exclusion of NIFTP.
    Özkara SK; Bayrak BY; Turan G
    Diagn Cytopathol; 2020 Nov; 48(11):986-997. PubMed ID: 32745375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology.
    Yazgan A; Balci S; Dincer N; Kiyak G; Tuzun D; Ersoy R; Cakir B; Guler G
    Cytopathology; 2014 Jun; 25(3):185-9. PubMed ID: 24024935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines.
    Lee JH; Han K; Kim EK; Moon HJ; Yoon JH; Park VY; Kwak JY
    Ann Otol Rhinol Laryngol; 2017 Sep; 126(9):625-633. PubMed ID: 28719972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of malignancy rates in different diagnostic categories of the Bethesda system for reporting thyroid cytopathology: An institutional experience.
    Arul P; Akshatha C; Masilamani S
    Biomed J; 2015 Dec; 38(6):517-22. PubMed ID: 27013451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
    Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
    Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A meta-analytic review of the Bethesda System for Reporting Thyroid Cytopathology: Has the rate of malignancy in indeterminate lesions been underestimated?
    Straccia P; Rossi ED; Bizzarro T; Brunelli C; Cianfrini F; Damiani D; Fadda G
    Cancer Cytopathol; 2015 Dec; 123(12):713-22. PubMed ID: 26355876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic Performance of Ultrasound Patterns by K-TIRADS and 2015 ATA Guidelines in Risk Stratification of Thyroid Nodules and Follicular Lesions of Undetermined Significance.
    Hong HS; Lee JY
    AJR Am J Roentgenol; 2019 Aug; 213(2):444-450. PubMed ID: 31039023
    [No Abstract]   [Full Text] [Related]  

  • 31. Risk factors associated with malignancy and with triage to surgery in thyroid nodules classified as Bethesda category III (AUS/FLUS).
    Kuru B; Atmaca A; Tarim IA; Kefeli M; Topgul K; Yoruker S; Elmali M; Danaci M
    Eur J Surg Oncol; 2016 Jan; 42(1):87-93. PubMed ID: 26527545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytopathology of non-invasive follicular thyroid neoplasm with papillary-like nuclear features: A comparative study with similar patterned papillary thyroid carcinoma variants.
    Mahajan S; Agarwal S; Kocheri N; Jain D; Mathur SR; Iyer VK
    Cytopathology; 2018 Jun; 29(3):233-240. PubMed ID: 29638022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A histological assessment of the Bethesda system for reporting thyroid cytopathology (2010) abnormal categories: a series of 219 consecutive cases.
    Tepeoğlu M; Bilezikçi B; Bayraktar SG
    Cytopathology; 2014 Feb; 25(1):39-44. PubMed ID: 23438201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in risk of malignancy and management recommendations in subcategories of thyroid nodules with atypia of undetermined significance or follicular lesion of undetermined significance: the role of ultrasound-guided core-needle biopsy.
    Choi YJ; Baek JH; Ha EJ; Lim HK; Lee JH; Kim JK; Song DE; Shong YK; Hong SJ
    Thyroid; 2014 Mar; 24(3):494-501. PubMed ID: 23947771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid nodules classified as atypia or follicular lesions of undetermined significance deserve further research: Analysis of 305 surgically confirmed nodules.
    Turkyilmaz S; Ulusahin M; Celebi B; Cekic AB; Mungan S; Kucuktulu U; Tasdelen A; Guner A; Cinel A
    Cytopathology; 2017 Oct; 28(5):391-399. PubMed ID: 28714532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).
    Ho AS; Sarti EE; Jain KS; Wang H; Nixon IJ; Shaha AR; Shah JP; Kraus DH; Ghossein R; Fish SA; Wong RJ; Lin O; Morris LG
    Thyroid; 2014 May; 24(5):832-9. PubMed ID: 24341462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subclassification of the Bethesda Category III (AUS/FLUS): A study of thyroid FNA cytology based on ThinPrep slides from the National Cancer Center in China.
    Zhao H; Guo H; Zhao L; Cao J; Sun Y; Wang C; Zhang Z
    Cancer Cytopathol; 2021 Aug; 129(8):642-648. PubMed ID: 34139103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of malignancy in Thyroid "Atypia of undetermined significance/Follicular lesion of undetermined significance" and its subcategories - A 5-year experience.
    Thakur A; Sarin H; Kaur D; Sarin D
    Indian J Pathol Microbiol; 2019; 62(4):544-548. PubMed ID: 31611437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of the 3rd Edition of the Bethesda System for Reporting Thyroid Cytopathology on Grey Zone Categories.
    Guerreiro SC; Tastekin E; Mourao M; Loureiro I; Eusebio R; Marques HP; Oznur M; Caliskan CK; Schmitt FC; Bongiovanni M; Canberk S
    Acta Cytol; 2023; 67(6):593-603. PubMed ID: 37899024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignancy risk stratification in thyroid nodules with nondiagnostic results at cytologic examination: combination of thyroid imaging reporting and data system and the Bethesda System.
    Moon HJ; Kim EK; Yoon JH; Kwak JY
    Radiology; 2015 Jan; 274(1):287-95. PubMed ID: 25133852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.